Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
Song, Joon Young, Choi, Won Suk, Heo, Jung Yeon, Lee, Jin Soo, Jung, Dong Sik, Kim, Shin-Woo, Park, Kyung-Hwa, Eom, Joong Sik, Jeong, Su Jin, Lee, Jacob, Kwon, Ki Tae, Choi, Hee Jung, Sohn, Jang Wook, Kim, Young Keun, Noh, Ji Yun, Kim, Woo Joo, Roman, François, Ceregido, Maria Angeles, Solmi, Francesca, Philippot, Agathe, Walls, Alexandra C., Carter, Lauren, Veesler, David, King, Neil P., Kim, Hun, Ryu, Ji Hwa, Lee, Su Jeen, Park, Yong Wook, Park, Ho Keun, Cheong, Hee Jin
Published in EClinicalMedicine (01.09.2022)
Published in EClinicalMedicine (01.09.2022)
Get full text
Journal Article
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
Song, Joon Young, Choi, Won Suk, Heo, Jung Yeon, Kim, Eun Jin, Lee, Jin Soo, Jung, Dong Sik, Kim, Shin-Woo, Park, Kyung-Hwa, Eom, Joong Sik, Jeong, Su Jin, Lee, Jacob, Kwon, Ki Tae, Choi, Hee Jung, Sohn, Jang Wook, Kim, Young Keun, Yoo, Byung Wook, Jang, In-Jin, Capeding, Maria Z., Roman, François, Breuer, Thomas, Wysocki, Piotr, Carter, Lauren, Sahastrabuddhe, Sushant, Song, Manki, D'Cor, Naveena, Kim, Hun, Ryu, Ji Hwa, Lee, Su Jeen, Park, Yong Wook, Cheong, Hee Jin, Philippot, Agathe, Solmi, Francesca, Ceregido, Maria Angeles, Shim, Byoung-Shik, Seo, Sang Hwan, D'Souza, Simone, Thaisrivichai, Patchara, Carlos, Josefina, Alberto, Edison, Nitayaphan, Sorachai, Ratanasuwan, Winai, Mootsikapun, Piroon, Chaiwarith, Romanee, Chan Quang, Luong, Karpenko, Olena, Yurkiv, Tatiana, Kutovyi, Vitalii, Bartko, Angela, Gyrina, Olga, Barna, Olga, Pugach, Mykhailo, Thurlow, Claire, Carson, Simon, Smith, Susan, Williams, Mike, Hemi Senior, Tiwini, Humphrey, Tim, Sheahan, Davitt, Park, Hokeun, Lee, Yoon Yeong, Kang, Seung Gu
Published in EClinicalMedicine (01.10.2023)
Published in EClinicalMedicine (01.10.2023)
Get full text
Journal Article
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialResearch in context
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Eun Jin Kim, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Byung Wook Yoo, In-Jin Jang, Maria Z. Capeding, François Roman, Thomas Breuer, Piotr Wysocki, Lauren Carter, Sushant Sahastrabuddhe, Manki Song, Naveena D'Cor, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Hee Jin Cheong, Agathe Philippot, Francesca Solmi, Maria Angeles Ceregido, Byoung-Shik Shim, Sang Hwan Seo, Simone D'Souza, Patchara Thaisrivichai, Josefina Carlos, Edison Alberto, Sorachai Nitayaphan, Winai Ratanasuwan, Piroon Mootsikapun, Romanee Chaiwarith, Luong Chan Quang, Olena Karpenko, Tatiana Yurkiv, Vitalii Kutovyi, Angela Bartko, Olga Gyrina, Olga Barna, Mykhailo Pugach, Claire Thurlow, Simon Carson, Susan Smith, Mike Williams, Tiwini Hemi Senior, Tim Humphrey, Davitt Sheahan, Hokeun Park, Yoon Yeong Lee, Seung Gu Kang
Published in EClinicalMedicine (01.10.2023)
Get full text
Published in EClinicalMedicine (01.10.2023)
Journal Article